John Stuelpnagel Insider Profile
25 Followers
John Stuelpnagel, Director at 10x Genomics, holds 328.44K shares in 10x Genomics (Ticker: TXG), holds 337.84K shares in Illumina (Ticker: ILMN). Most recently, John Stuelpnagel Sold ― shares of 10x Genomics on Sep 08, 2026 for an estimated value of $1.23M.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+25.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Stuelpnagel holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Stuelpnagel
John Stuelpnagel's Trading History
10x Genomics
Sep 08, 2026
Director
Informative Sell
1.23M
$22.53M
Illumina
―
Sr VP and COO, Director
―
$69.75M
List of latest transactions for each holding click on a transaction to see John Stuelpnagel's performance on stock
You May Also Like
John Stuelpnagel insider profile FAQ
What is the percentage of profitable transactions made by John Stuelpnagel?
The percentage of profitable transactions made by John Stuelpnagel is 50%.
What is the average return per transaction made by John Stuelpnagel?
The average return per transaction made by John Stuelpnagel is 25.90%.
What stocks does John Stuelpnagel hold?
John Stuelpnagel holds: TXG, ILMN stocks.
What was John Stuelpnagel’s latest transaction?
John Stuelpnagel latest transaction was an Informative Sell of $1.23M.
What was John Stuelpnagel's most profitable transaction?
John Stuelpnagel’s most profitable transaction was an Informative Sell of TXG stock on June 7, 2023. The return on the trade was 59.50%.
What is John Stuelpnagel's role in 10x Genomics?
John Stuelpnagel's role in 10x Genomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.